Retatrutide
10mg/vial
Triple-Action Metabolic Optimization
Retatrutide is a novel triple agonist peptide that targets GLP-1, GIP, and glucagon receptors simultaneously. This multi-pathway approach enables comprehensive metabolic optimization, supporting glucose homeostasis, appetite regulation, and enhanced energy expenditure.
Research Metrics
HPLC verified purity
Triple receptor activation
Extended duration
Subcutaneous absorption
Mechanism of Action
Retatrutide binds to GLP-1, GIP, and glucagon receptors, triggering a cascade of metabolic signals. GLP-1 activation promotes insulin secretion and appetite control. GIP binding enhances glucose-dependent insulin release. Glucagon receptor activation stimulates hepatic energy expenditure and thermogenesis.
Scientific Benefits
- Activates three distinct metabolic pathways for synergistic effects
- Supports natural glucose regulation and insulin sensitivity
- Enhances thermogenesis and metabolic rate
- Promotes satiety signaling through GLP-1 pathway
- Supports hepatic lipid metabolism via glucagon activation
Ingredient Transparency
Disclaimer & Usage Notice
GENERAL USAGE NOTICE. The products offered on this website are sold strictly for your own personal purposes. By purchasing, you acknowledge that you are assuming all risks associated with the handling and application of these products.
